ANTIBODIES
Contributor Information
- Institute UK Health Security Agency (UKHSA / PHE)
Tool Details
- Tool name: Anti-Botulinum neurotoxin monoclonal antibody [5BA2.3]
- Clone: 5BA2.3
- Tool type: Antibody
- Tool sub-type: Primary Antibody
- Class: Monoclonal
- Conjugate: Horseradish peroxidase (HRP)
- Reactivity: Clostridium botulinum
- Host: Mouse
- Molecular weight of the target: 150 kDa
- Description: Clostridium botulinum neurotoxins are produced by the spore-forming bacteria with the same name and can lead to life-threatening botulism, having major implications for food safety. Botulinum toxins cause muscle paralysis by blocking acetylcholine, and this property of botulinum toxin A is used to treat several muscular and dermatological disorders. More recently, its popularity has extended in cancer therapy to provide analgesia in spastic conditions. The HRP-conjugated anti-Clostridium botulinum neurotoxin A antibody provides a valuable tool for target detection. This tool is suitable for researching the mechanisms and effects of the widely used Clostridium botulinum neurotoxin A, as well as dosing studies or quality control.
- Isotype: IgG
- Research area: Cancer; Neurobiology
- Additional notes: HRP conjugation done with concentrated purified antibody at > 4 mg/mL using Peroxidase labelling kit (Roche)
- For Research Use Only
Target Details
- Target: Clostridium botulinum neurotoxin A
- Target alternate names: Botulinum toxin A, bontoxilysin-A (BOTOX), BoNT/A
- Target molecular weight: 150 kDa
- Target background: Clostridium botulinum neurotoxin A (BoNT A) is one of the seven serotypes of Clostridium botulinum toxins. BoNT A consists of an inactive 1296 AA long polypeptide chain of approximately 150 kDa which is cleaved by endogenous proteases. After cleavage, BoNT A becomes active in the form of a molecule with a light chain and a heavy chain. The light chain has protease activity, whilst the heavy chain containing a translocation domain and a two-units receptor binding domain. BoNT A binds to a corresponding receptor on the neuronal surface through its heavy chain, whilst the light chain cleaves a key component in exocytosis at the synaptic level, therefore blocking the release of acetylcholine and action potential transmission. Wheeler and Smith. 2013. Toxicology. 306: 124-146. PMID: 23435179 ; UniProt ID: P0DPI0
Application Details
- Application notes: Supplied at 1 mg/mL.
Handling
- Storage buffer: PBS / 10 mM glycine pH 7.4 and 0.01% thimerosal
- Storage conditions: Store at -20°C
Documentation
.svg)
.svg)
